A physico-chemical study on amphiphilic cyclodextrin/liposomes nanoassemblies with drug carrier potential

References

• Bala, I., Hariharan, S., and Kumar, M.N., 2004. PLGA nanoparticles in drug delivery: the state of the art. Critical reviews in therapeutic drug carrier systems, 21(5), 387–422.
   PubMed Web of Science ®Google Scholar
• Bilensoy, E. and Hincal, A.A., 2009. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles. Expert opinion on drug delivery, 6(11), 1161–1173.
   PubMed Web of Science ®Google Scholar
• Bonnet, V., et al., 2015. Cyclodextrin nanoassemblies: a promising tool for drug delivery. Drug discovery today, 20(9), 1120–1126.
   PubMed Web of Science ®Google Scholar
• Cannavà, C., et al., 2013. Celecoxib-loaded PLGA/cyclodextrin microspheres: characterization and evaluation of anti-inflammatory activity on human chondrocyte cultures. Colloids and surfaces B: biointerfaces, 111, 289–296.
   PubMed Web of Science ®Google Scholar
• Cannavà, C., et al., 2016. Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect. RSC advances, 6(20), 16720–16729.
   Web of Science ®Google Scholar
• Cho, E., et al., 2016. Regioselective self-acylating cyclodextrins in organic solvent. Scientific reports, 6(1), 23740.
   PubMedGoogle Scholar
• Falvey, P., et al., 2005. Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules. Chemistry – a European journal, 11(4), 1171–1180.
   PubMed Web of Science ®Google Scholar
• Gallois-Montbrun, D., et al., 2007. Direct synthesis of novel amphiphilic cyclodextrin. Journal of inclusion phenomena and macrocyclic chemistry, 57(1–4), 131–135.
   Web of Science ®Google Scholar
• Gill, P., Moghadam, T.T., and Ranjbar, B., 2010. Differential scanning calorimetry techniques: applications in biology and nanoscience. Journal of biomolecular techniques: JBT, 21(4), 167–193.
   PubMedGoogle Scholar
• Hatzi, P., et al., 2007. Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition. International journal of pharmaceutics, 333(1–2), 167–176.
   PubMed Web of Science ®Google Scholar
• Kauscher, U., et al., 2013. Incorporation of amphiphilic cyclodextrins into liposomes as artificial receptor units. Langmuir, 29(24), 7377–7383.
   PubMed Web of Science ®Google Scholar
• Lauro, F., et al., 2016. Pharmacological effect of a new idebenone formulation in a model of carrageenan-induced inflammatory pain. Pharmacological research, 111, 767–773.
   PubMed Web of Science ®Google Scholar
• Lesieur, S., et al., 2000. Phase behavior of fully hydrated DMPC-amphiphilic cyclodextrin systems. Chemistry and physics of lipids, 106(2), 127–144.
   PubMed Web of Science ®Google Scholar
• Liossi, A.S., et al., 2017. Exploring the interactions of irbesartan and irbesartan – 2-hydroxypropyl-β-cyclodextrin complex with model membranes. Biochimica et biophysica acta (BBA) – biomembranes, 1859(6), 1089–1098.
   PubMed Web of Science ®Google Scholar
• Loftsson, T. and Brewster, M.E., 2010. Pharmaceutical applications of cyclodextrins: basic science and product development. Journal of pharmacy and pharmacology, 62(11), 1607–1621.
   PubMed Web of Science ®Google Scholar
• Mazzaglia, A., et al., 2001. Novel amphiphilic cyclodextrins: graft-synthesis of heptakis (6-deoxy-6alkylthio) beta-cyclodextrin 2-oligo(ethylene-glycol) conjugates and their w-halo derivatives. European journal of organic chemistry, 2001(9), 1715–1721.
   Web of Science ®Google Scholar
• Musumeci, T., et al., 2008. Development of liposome formulation for d-cycloserine local delivery. Journal of liposome research, 18(3), 211–224.
   PubMed Web of Science ®Google Scholar
• Musumeci, T., et al., 2013. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits. International journal of pharmaceutics, 440(2), 135–140.
   PubMed Web of Science ®Google Scholar
• Nishijo, J., et al., 2000. Interactions of cyclodextrins with dipalmitoyl, distearoyl, and dimyristoyl phosphatidyl choline liposomes. A study by leakage of carboxyfluorescein in inner aqueous phase of unilamellar liposomes. Chemical & pharmaceutical bulletin, 48(1), 48–52.
   PubMed Web of Science ®Google Scholar
• Pignatello, R., et al., 2011. Biomembrane models and drug-biomembrane interaction studies: involvement in drug design and development. Journal of pharmacy and bioallied sciences, 3(1), 4–14.
   PubMedGoogle Scholar
• Puskás, I. and Csempesz, F., 2007. Influence of cyclodextrins on the physical stability of DPPC-liposomes. Colloids and surfaces B: biointerfaces, 58(2), 218–224.
   PubMed Web of Science ®Google Scholar
• Quaglia, F., et al., 2009. The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs. Biomaterials, 30(3), 374–382.
   PubMed Web of Science ®Google Scholar
• Rascol, E., Devoisselle, J.M., and Chopineau, J., 2016. The relevance of membrane models to understand nanoparticles–cell membrane interactions. Nanoscale, 8(9), 4780–4798.
   PubMed Web of Science ®Google Scholar
• Ravoo, B.J. and Darcy, R., 2000. Cyclodextrin bilayer vesicles. Angewandte chemie (international ed. in English), 39(23), 4324–4326.
   PubMed Web of Science ®Google Scholar
• Stancanelli, R., et al., 2010. Amphiphilic cyclodextrins as nanocarriers of genistein: a spectroscopic investigation pointing out the structural properties of the host/drug complex system. Journal of pharmaceutical sciences, 99(7), 3141–3149.
   PubMed Web of Science ®Google Scholar
• Stancanelli, R., et al., 2012. Structural and spectroscopic features of lutein/butanoyl-β-cyclodextrin nanoassemblies. Journal of pharmaceutical and biomedical analysis, 71, 214–218.
   PubMed Web of Science ®Google Scholar
• Varan, G., et al., 2017. Amphiphilic cyclodextrin nanoparticles. International journal of pharmaceutics, 531(2), 457–469.
   PubMed Web of Science ®Google Scholar
• Wouessidjewe, D., et al., 1996. A new concept in drug delivery based on skirt-shaped cyclodextrin aggregates, present state and future prospects. STP pharma sciences, 6(1), 21–28.
   Google Scholar
• Xu Z., et al., 2015. Unimolecular micelles of amphiphilic cyclodextrin-core star-like block copolymers for anticancer drug delivery, Chemical communications (Camb), 51(87), 15768–15771.
   PubMed Web of Science ®Google Scholar
• Zerkoune, L., Angelova, A., and Lesieur, S., 2014. Nano-assemblies of modified cyclodextrins and their complexes with guest molecules: incorporation in nanostructured membranes and amphiphile nanoarchitectonics design. Nanomaterials, 4(3), 741–765.
   Web of Science ®Google Scholar
• Zylberberg, C. and Matosevic, S., 2016. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape. Drug delivery, 23(9), 3319–3329.
   PubMed Web of Science ®Google Scholar